In the transwell assay, the migration and invasion of glioma cells in the shDTX2 group were greatly reduced compared with the control group (Fig. 3A, B), whereas in the overexpressed DTX2 group they were greatly increased (Fig. 3C, D). The gene discussed is DTX2; the disease is central nervous system cancer.